Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market for neuroprosthetics is getting very big, pushed by new technology and more neurological problems happening. Neuroprosthetics uses fake devices to change or boost the work of the nervous system. This gives hope for people with disabilities. One big cause of changes in market trends is the growing number of brain-related health issues, like Parkinson's disease, seizures, and backbone injuries.
As more people get older all over the world, there is growing need for new brain-machine solutions to make life better for those it impacts. Big tech changes quickly help to shape the neuroprosthetics market. Getting smaller, being better for the body and having improved connections are important changes. They make it easier to join brain-cooking gadgets with our nervous system in a more natural way.
The growth of Brain-Machine Interfaces (BMIs) is a big change happening in neuroprosthetics. These connections let the brain talk straight with things outside, creating new chances to control fake arms or computers. This could even be used for robots using our thoughts alone. A big increase in money for research and development is driving new ideas about brain prosthetics. Governments, private firms and schools are giving money to look at new ways of making thing like brain-machine devices.
They want these things to work better for more people. People are starting to use wearable brain devices more often. These help them move around better and have more freedom in life. These tools, like exoskeletons and smart glasses, are made to help people with muscle problems do everyday tasks more easily. Neural implants are important parts of neuroprosthetics. Recent updates in this area have made these devices more accurate and longer lasting.
Better body-friendly materials and advanced surgery methods help make neural implants successful and accepted. More health workers and people are getting used to it, helping the market grow. As brain-prosthetic technologies become more common, the feelings against these devices are getting less. This is making people accept them and use them more often.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Opportunities | New product launches and R&D Amongst major key Players Key Market Drivers Increasing prevalence of neural diseases Over active bladder syndrome and Chronic disorder |
Neuroprosthetics Market Highlights:
Neuroprosthetics Market Overview
The neuroprosthetics market was valued USD 14.3 billion in 2021 and is expected to reach USD 21.5 billion by 2030 at 11.8% CAGR during the forecast period 2022-2030. Neuroprosthetics are medical devices that are designed to send signals to the central nervous system while also receiving input from the outside world. These devices are employed in the treatment of neurological illnesses like epilepsy, Parkinson's disease, and visual prosthetics, among others. The increasing frequency of neurological diseases, overactive bladder syndrome, and chronic disorders such as epilepsy are driving this market's favorable expansion. The rising number of patients suffering from neurological disorders and nerve injury, the rising incidence of hearing loss, the increasing cases of amputations due to the rising number of accidents and injuries, and the rising prevalence of diabetes are the major factors driving the market growth of the Neuroprosthetics.
Diabetes patients may develop a variety of foot problems, including blood vessel and nerve damage. Also, diabetes can harm the blood vessels in the retina, resulting in vision problems or blindness. As a result, the growing prevalence of diabetes is predicted to boost demand for retinal/bionic eye implants. Amputations due to dysvascular disorders and diabetes are projected to fuel demand for mechanical limb replacements soon leading to the growth in Neuroprosthetics Market. Diabetes has a large regional difference in prevalence. Because the weight of this factor is larger in the Asia Pacific area, it is likely to have a greater impact on the market in Southeast Asia and the Indian subcontinent.
MED-El got European Medical Device Regulation (MDR) certification in March 2020. MED-El is one of the first manufacturers in the world to be certified for medical devices in the highest risk class (Class III), Class III Implantable Custom-Made Devices, and Class I reusable surgical instruments. Cochlear Limited gained FDA permission in March 2020 to reduce the age of cochlear implantation for children with bilateral, significant sensorineural hearing loss from 12 months to 9 months in the Neuroprosthetics Market.
Neuroprosthetics Market Segment Insights:
The neuroprosthetics market is segmented on the basis of type, technology, applications, and end users.
Neuroprosthetics Type Insights
On the basis of type the market is segmented into output neural prosthetics and input neural prosthetics. The output is segmented into cognitive prosthetics, and motor prosthetics. The input is segmented into cochlear implant, and visual prosthetic.
Neuroprosthetics Technology Insights
On the basis of techniques, the market is segmented into vagus nerve stimulation, deep brain stimulation, sacral nerve stimulation, and spinal cord stimulation.
Neuroprosthetics Application Insights
On the basis of application, the market is segmented into motor neuron disorders, physiological disorders, and cognitive disorders. The motor neuron disorders are segmented into Parkinson’s disease, and Epilepsy disorder. The physiological disorders are segmented into auditory processing disorders, ophthalmic disorders, cardiovascular disorders, and urology disorders. Furthermore, the cognitive disorders include disorders such as Alzheimer’s disease, paralysis, and severe depression. On the basis of end-users, the market is segmented into hospitals and clinics, diagnostic centers, research centers and others.
Neuroprosthetics Regional Insights
On the basis of region, the market of Neuroprosthetics is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Key players:
Some of the key players in the neuroprosthetics global market are:
- Medtronic (US)
- Abbott (US)
- Cochlear (Australia)
- Boston Scientific (US)
- Livanova (UK)
- Second Sight (US)
- Med-El (UK)
- Retina Implant (US)
- Sonova (UK)
- Neuropace (US)
- Nevro (California), and others.
Regional Market Summary: Global Neuroprosthetics Market Share (%), by Region
Sources: National Cancer Institute, Cancer research UK, the American Cancer Society, Inc., US Department of Health and Human Services National Institutes of Health
It is estimated that North America dominated the market of neuroprosthetics owing to the increasing in the prevalence of neural diseases such as Epilepsy, Parkinson’s disease. According to the Parkinson's Foundation it has been estimated that in the U.S. approximately one million people may live with Parkinson's disease (PD) by 2020. It was also reported that around 60,000 Americans get diagnosed with Parkinson's disease each year.
Such a high prevalence of Parkinson's disease in this region may support the market growth during the forecasted period.
Europe stood second largest in the neuroprosthetics market owing to the increasing number of patients diagnose with Parkinson disorder. According to the Parkinson’s UK 2018, the number of adults living and diagnosed with Parkinson’s is increasing rapidly, it has been estimated that approximately 145,000 number of people are diagnosed with Parkinson’s in 2018 in the UK. Such high prevalence Parkinson and increasing geriatric population in this region facilitates the market growth.
Asia-Pacific was projected to be the rapidly growing region for the neuroprosthetics global market. The market is expected to witness growth owing to the increasing various technological for developing neuroprosthetics devices, rising cognitive disorders such as paralysis, Alzheimer’s disease, and severe depression. According to the National Center for Biotechnology Information 2016, Alzheimer’s disease accounts for up to 60% cases in Asia. The increasing number of Alzheimer patients in Asia region will support the market growth positively.
The Middle East and Africa holds low market share in the neuroprosthetics due to, low awareness about the available neuroprosthetics devices, and lack of well-defined standards and treatment guidelines for neurological disorders. However, the market is expected to witness growth due to increasing government imitative programs related to creating awareness about the various diseases and their treatment methods in the Middle East.Recent Development
MED-El got European Medical Device Regulation (MDR) certification in March 2020. MED-El is one of the first manufacturers in the world to be certified for medical devices in the highest risk class (Class III), Class III Implantable Custom-Made Devices, and Class I reusable surgical instruments. Cochlear Limited gained FDA permission in March 2020 to reduce the age of cochlear implantation for children with bilateral, significant sensorineural hearing loss from 12 months to 9 months in the Neuroprosthetics Market.
Intended Audience
- Government and private laboratories
- Hospitals and clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Market research and consulting service providers
Neuroprosthetics Market Segmentation
Neuroprosthetics Type Outlook
- Output Neural Prosthetics
- Cognitive Prosthetics
- Motor Prosthetics
- Input Neural Prosthetics
- Cochlear Implant
- Visual Prosthetics
Neuroprosthetics Techniques Outlook
- Deep Brain stimulation,
- Vagus Nerve stimulation
- Sacral Nerve Stimulation
- Spinal Cord stimulation
Neuroprosthetics Application Outlook
- Motor Neuron Disorders
- Parkinson’s Disease
- Epilepsy
- Physiological Disorders
- Auditory Processing Disorders
- Ophthalmic Disorders
- Cardiovascular Disorders,
- Urology Disorders
- Cognitive Disorders
- Alzheimer’s Disease
- Paralysis
- Severe Depression
Neuroprosthetics End-Users Outlook
- Hospitals and clinics
- Diagnostic centers
- Research centers
- Others
Neuroprosthetics Region Outlook
- Americas
- Europe
- Asia-Pacific
- Middle East & Africa
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
